comparemela.com
Home
Live Updates
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca : comparemela.com
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
Second novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's drug discovery platform and selected for AstraZeneca's drug development portfolioA total of three targets
Related Keywords
New York ,
United States ,
London ,
City Of ,
United Kingdom ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Anne Phelan ,
Prnewswire Benevolentai Euronext ,
Maria Belvisi ,
Astrazeneca ,
Head Of Research ,
Early Development ,
Euronext Amsterdam ,
Benevolent Platform ,
Knowledge Graph ,
Chief Scientific Officer ,
Benevolentai ,
Chieves ,
Third ,
Milestone ,
Nabled ,
Drug ,
Discovery ,
Collaboration ,
comparemela.com © 2020. All Rights Reserved.